IM Cannabis (IMCC) Depreciation & Amortization (CF) (2020 - 2026)
IM Cannabis (IMCC) recorded quarterly Depreciation & Amortization (CF) of $26980.6 in Q1 2026, down 57.24% quarter-over-quarter from $63103.6 in Q4 2025, and down 15.84% on a YoY basis from $32058.2 in Q1 2025.
IM Cannabis (IMCC) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
IM Cannabis' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $26980.6 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 15.84% year-over-year to $26980.6; the TTM figure through Mar 2026 stood at $210302.0 (down 17.94% YoY), while the FY2025 annual figure was $215125.9, down 35.41% from the prior year.
- Depreciation & Amortization (CF) was $26980.6 for Q1 2026 at IM Cannabis, down from $63103.6 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $819475.5 in Q1 2022 to a low of $26980.6 in Q1 2026.
- Historically, Depreciation & Amortization (CF) has averaged $200464.0 across 5 years, with a median of $109090.6 in 2024.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 305.15% in 2022, then sank 84.29% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $378665.3 in 2022, then sank by 70.9% to $110180.3 in 2023, then decreased by 19.44% to $88765.3 in 2024, then declined by 28.91% to $63103.6 in 2025, then plunged by 57.24% to $26980.6 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $26980.6 (Q1 2026), $63103.6 (Q4 2025), and $61037.3 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | IM Cannabis | 49,978.63 | -735,375.90 | 1.03 Mn | 26,980.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,980.61 |
| Mar 31, 2026 | 26,980.61 |
| Dec 31, 2025 | 63,103.59 |
| Dec 31, 2025 | 63,103.59 |
| Sep 30, 2025 | 61,037.34 |
| Sep 30, 2025 | 61,037.34 |
| Jun 30, 2025 | 59,180.42 |
| Jun 30, 2025 | 59,180.42 |
| Mar 31, 2025 | 32,058.16 |
| Mar 31, 2025 | 32,058.16 |
| Dec 31, 2024 | 88,765.29 |
| Dec 31, 2024 | 88,765.29 |
| Sep 30, 2024 | 77,703.66 |
| Sep 30, 2024 | 77,703.66 |
| Jun 30, 2024 | 57,760.10 |
| Jun 30, 2024 | 57,760.10 |
| Mar 31, 2024 | 109,090.64 |
| Mar 31, 2024 | 109,090.64 |
| Dec 31, 2023 | 110,180.33 |
| Dec 31, 2023 | 110,180.33 |